Medical University of South Carolina - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
37
About the Report
About the Report
Summary
Medical University of South Carolina (MUSC) is a healthcare university that provides learning and discovery opportunities for health care professionals and biomedical scientists. The university conducts research on health sciences, and offers comprehensive healthcare services. It provides treatments for ailments including neurosciences, cardiology, diabetes, endocrinology and medical genetics, infectious disease, nephrology, anesthesia and perioperative medicine, obstetrics and gynecology, dermatology, pulmonary and critical care, and urology. MUSC also provides educational programs in the areas of dental medicine, graduate studies, health professions, medicine, nursing and pharmacy. The university operates through a network of colleges. It also operates through medical service centers, cancer care center, vascular center, and institutes in different parts of the US. MUSC is headquartered in Charleston, South Carolina, the US.
Medical University of South Carolina-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Medical University of South Carolina, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medical University of South Carolina, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medical University of South Carolina, Medical Devices Deals, 2012 to YTD 2018 9
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Bristol-Myers Squibb Enters into Research Agreement with Medical University of South Carolina 11
Berg To Enter Into Agreement With Medical University Of South Carolina For Lupus Biomarker Discovery 12
iBio Amends Agreement with Medical University of South Carolina 13
Licensing Agreements 14
CharlestonPharma Enters into Licensing Agreement with Medical University of South Carolina 14
CharlestonPharma Enters into Licensing Agreement with Medical University of South Carolina 15
Medical University of South Carolina-Key Competitors 16
Medical University of South Carolina-Key Employees 17
Medical University of South Carolina-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Jul 24, 2018: Parkinson's Foundation designates three centers of excellence in parkinson's care 19
Dec 07, 2017: Teamwork makes heart procedures less invasive, reduces recovery time 20
Nov 16, 2017: MUSC leads research on potential lupus treatment 22
May 17, 2017: Antibody that neutralizes sMIC boosts CTLA4 immunotherapy response and reduces colitis 24
May 09, 2017: Colorectal tumors initiate VEGF-A/CXCL1 cascade, creating distant niches for metastases 26
Apr 06, 2017: Stem cell drug screen yields potential alternative to statins 27
Mar 13, 2017: A novel protein regulates cancer immunity and could offer a therapeutic target 28
Jan 11, 2017: A novel cancer immunotherapy shows early promise in preclinical studies 29
Product News 30
May 16, 2018: Novel therapy inhibits complement to preserve neurons and reduce inflammation after stroke 30
Jan 26, 2018: Pyridostigmine treatment reverses pediatric complications of botulinum toxin therapy 32
Other Significant Developments 34
Aug 15, 2018: 'BOOST-3' Trial Seeks to Improve Outcomes After Severe Traumatic Brain Injury 34
Jun 14, 2017: Johnson & Johnson Medical Devices Companies Bring Real-World Evidence to Infection Risk Management to Help Medical University of South Carolina Reduce Infection Risk in the OR 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Figure
List of Figures
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medical University of South Carolina, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Medical University of South Carolina, Pharmaceuticals & Healthcare, Key Facts 2
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medical University of South Carolina, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medical University of South Carolina, Deals By Therapy Area, 2012 to YTD 2018 8
Medical University of South Carolina, Medical Devices Deals, 2012 to YTD 2018 9
Medical University of South Carolina, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bristol-Myers Squibb Enters into Research Agreement with Medical University of South Carolina 11
Berg To Enter Into Agreement With Medical University Of South Carolina For Lupus Biomarker Discovery 12
iBio Amends Agreement with Medical University of South Carolina 13
CharlestonPharma Enters into Licensing Agreement with Medical University of South Carolina 14
CharlestonPharma Enters into Licensing Agreement with Medical University of South Carolina 15
Medical University of South Carolina, Key Competitors 16
Medical University of South Carolina, Key Employees 17
Medical University of South Carolina, Subsidiaries 18
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.